Friday, December 16, 2011

GlaxoSmithKline plc (ADR) at its Peak Price of the Year - NYSE:GSK

GlaxoSmithKline plc (ADR) (NYSE:GSK) achieved its new 52 week high price of $44.42 where it was opened at $44.00 UP 0.30 points or +0.68% by closing at $44.21. GSK transacted shares during the day were over 2.27 million shares however it has an average volume of 1.94 million shares.

GSK has a market capitalization $112.45 billion and an enterprise value at $125.97 billion. Trailing twelve months price to sales ratio of the stock was 2.54 while price to book ratio in most recent quarter was 7.72. In profitability ratios, net profit margin in past twelve months appeared at 6.59% whereas operating profit margin for the same period at 32.04%.

The company made a return on asset of 12.70% in past twelve months and return on equity of 19.16% for similar period. In the period of trailing 12 months it generated revenue amounted to $44.35 billion gaining $17.43 revenue per share. Its year over year, quarterly growth of revenue was -10.50% holding 13.80% quarterly earnings growth.

According to preceding quarter balance sheet results, the company had $10.71 billion cash in hand making cash per share at 4.21. The total of $24.22 billion debt was there putting a total debt to equity ratio 152.59. Moreover its current ratio according to same quarter results was 1.28 and book value per share was 5.73.

Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated 24.66% where the stock current price exhibited up beat from its 50 day moving average price of $42.46 and remained above from its 200 Day Moving Average price of $40.16.

GSK holds 2.54 billion outstanding shares with 2.42 billion floating shares.

No comments:

Post a Comment